Creative Medical Technology Holdings, Inc. (CELZ) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Phoenix, AZ, 미국. 현재 CEO는 Timothy Warbington.
CELZ 을(를) 보유 IPO 날짜 2015-11-06, 4 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $5.91M.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
